Diagnostics

cancer target detection radiopharma radio
Favicon Fierce Biotech

Tempus buys out Personalis in $1.5 billion deal

Tempus is boosting its cancer offerings with a deal to buy out Personalis three years after the pair first teamed up in oncology.
Ben Adams Jul 20, 2026 9:55am
blood test vial
Favicon Fierce Biotech

Labcorp joins lab results personalization push with ‘MyLabcorp’

May 20, 2026 9:10am
Quest Diagnostics
Favicon Fierce Biotech

Quest launches AI chatbot to explain lab results

Mar 2, 2026 9:00am
GE HealthCare MRI Signa Magnus
Favicon Fierce Biotech

GE HealthCare to acquire Intelerad for $2.3B

Nov 20, 2025 4:34pm
Cologuard Exact Sciences
Favicon Fierce Biotech

Abbott inks $23B deal for Exact Sciences in cancer testing buy

Nov 20, 2025 10:30am
Apple Watch series 11 sensors
Favicon Fierce Biotech

Apple aims to catch 1M hypertension cases with new Apple Watch

Sep 10, 2025 10:30am